Lisa XL can perform up to 576 tests at one go, making it a preferred choice for laboratories and blood banks with high workload
The Transasia-Erba group recently unveiled Lisa XL, a six plate ELISA processor at the 15th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine Congress (APFCB) being held in Jaipur. The device was formally unveiled by Prof Praveen Sharma, Chairman, Organising Committee, APFCB Congress, in the presence of Ravi Kaushik, CEO, Transasia Bio-Medicals, Anil Jotwani, Sr President, Transasia Bio-Medicals and Louis Villar, Commercial Manager, South-East Asia, Erba Group. Designed at Transasia-Erba’s European subsidiary, Lisa XL can perform up to 576 tests at one go, making it a preferred choice for laboratories and blood banks with high workload. Transasia also displayed its entire suite of products in Biochemistry, Urinalysis and Haematology at the conference. The new instrument is already registered with the Government e-Marketing (GeM) a government digital e-market platform to sell Lisa XL.
Commenting on the new equipment, Jotwani said, “Today blood banks have to ensure stringent screening with quality instruments and reagent kits. Considering the high volume of testing in India, there is a need to equip blood banks here with the latest technology that enable faster diagnosis without compromising on quality. Also shorter turnaround time also leads to lower cost per test which is important considering pricing is a major factor in India. Microplate processors in India are one, two or four plates. By introducing a six plate processor, the first in the country, we are targeting large blood banks. The new Lisa XL is part of our commitment to making healthcare affordable in India through delivery of world-class diagnostics at competitive prices.”
A complete walk-away system, Lisa XL offers a host of features to maximise the efficiency of ELISA processing. Dual probes with powerful robotic engineering allow simultaneous and sequential dispensing of samples in less than 14 minutes and reagents in less than five minutes in 96 wells. Lisa XL processes serum and whole blood simultaneously. For greater accuracy, each microplate has a dedicated temperature controlled incubator with orbital shaking at variable speed. Further, multiple aspiration and Super Sweep Mode ensures superior washing with minimal residual volume.
The new Lisa XL will be highly beneficial in high workload settings for the accurate detection of transfusion transmitted infections like HIV, hepatitis B, hepatitis C, malaria and syphilis among others which are transmitted through blood. Not just the TTIs, Lisa XL is beneficial to evaluate a wide range of other biochemical markers for diabetes, steroid, inflammatory, autoimmune disorders, bone metabolism, tumour, cardiac and anaemia markers which can be performed by ELISA in high workload settings.
Villar speaking about Erba’s plan for the South-East Asian market he added, “We are very excited to be able to serve our customers across South-East Asia and support our channel partners from within Vietnam. We have a dedicated team ready to support our customers with application and service expertise as well as sales and marketing.”